foxo4 dri peptide senolytic 2023 study Molecular modelling of the FOXO4-TP53 interaction to design peptides for the elimination of senescent cancer foxo4-dri peptide senolytic 2023 FOXO4-DRI
foxo4 dri peptide senolytic 2023 FOXO4 DRI 10mg Research Peptide FOXO4 DRI Peptide 10 mg Development of a novel senolytic by precise disruption of FOXO4 p53 complex eBioMedicine The disordered p53 transactivation domain is the target of FOXO4 and the senolytic compound FOXO4 DRI Nature Communications
Pay in 4 interest-free payments of $5.05 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 6 - Aug 11



